Procter & Gamble Company (The) $PG Shares Sold by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 3.4% in the second quarter, according to its most recent filing with the SEC. The firm owned 42,051 shares of the company’s stock after selling 1,484 shares during the quarter. Chesley Taft & Associates LLC’s holdings in Procter & Gamble were worth $6,700,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of PG. Nuveen LLC bought a new position in shares of Procter & Gamble in the first quarter valued at approximately $1,954,941,000. GAMMA Investing LLC lifted its position in Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company’s stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Invesco Ltd. increased its position in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Procter & Gamble by 15.8% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company’s stock worth $2,728,430,000 after buying an additional 2,224,912 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. BNP Paribas reiterated an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Evercore ISI reiterated an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Wells Fargo & Company reduced their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $170.00 price target (down previously from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. Finally, Barclays set a $164.00 price objective on Procter & Gamble and gave the company an “equal weight” rating in a research report on Thursday, July 31st. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $175.12.

Read Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Performance

PG stock opened at $158.08 on Wednesday. The firm has a 50 day moving average of $156.14 and a two-hundred day moving average of $161.62. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The company has a market capitalization of $369.98 billion, a price-to-earnings ratio of 24.28, a P/E/G ratio of 4.14 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.7%. Procter & Gamble’s dividend payout ratio is currently 64.98%.

Insiders Place Their Bets

In other news, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the sale, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 in the last three months. 0.20% of the stock is owned by insiders.

Procter & Gamble Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.